Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
27
TROW Quote, Financials, Valuation and Earnings
Last price:
$91.55
Seasonality move
:
3.27%
Day range:
$93.86 - $95.41
52-week range:
$91.37 - $125.81
Dividend yield:
5.27%
P/E ratio:
10.34x
P/S ratio:
2.98x
P/B ratio:
2.04x
Volume:
1.6M
Avg. volume:
2M
1-year change:
-21.64%
Market cap:
$21.1B
Revenue:
$7.1B
EPS (TTM):
$9.16
Analysts' Opinion
-
Consensus RatingT. Rowe Price Group has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $110.54, T. Rowe Price Group has an estimated upside of 16.73% from its current price of $94.70.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $90.00 representing 100% downside risk from its current price of $94.70.
Fair Value
-
According to the consensus of 9 analysts, T. Rowe Price Group has 16.73% upside to fair value with a price target of $110.54 per share.
TROW vs. S&P 500
-
Over the past 5 trading days, T. Rowe Price Group has overperformed the S&P 500 by 1.32% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
T. Rowe Price Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
T. Rowe Price Group has grown year-over-year revenues for 7 quarters straight. In the most recent quarter T. Rowe Price Group reported revenues of $1.8B.
Earnings Growth
-
T. Rowe Price Group has grown year-over-year earnings for 7 quarters straight. In the most recent quarter T. Rowe Price Group reported earnings per share of $1.92.
Enterprise value:
19.5B
EV / Invested capital:
1.71x
Price / LTM sales:
2.98x
EV / EBIT:
7.89x
EV / Revenue:
2.75x
PEG ratio (5yr expected):
0.57x
EV / Free cash flow:
15.48x
Price / Operating cash flow:
16.75x
Enterprise value / EBITDA:
6.42x
Gross Profit (TTM):
$3.7B
Return On Assets:
16.06%
Net Income Margin (TTM):
29.61%
Return On Equity:
19.29%
Return On Invested Capital:
19.29%
Operating Margin:
32.88%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $6.5B | $6.5B | $7.1B | $1.6B | $1.8B | |
| Gross Profit | $3.6B | $3.2B | $3.7B | $762.8M | $947.6M | |
| Operating Income | $2.5B | $2B | $2.5B | $418.7M | $599.8M | |
| EBITDA | $3.1B | $2.6B | $3B | $718.7M | $915.6M | |
| Diluted EPS | $6.69 | $7.76 | $9.16 | $1.90 | $1.92 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3B | $2.6B | $2.5B | $2.9B | $3.5B | |
| Total Assets | $10.7B | $12.5B | $11.6B | $12.3B | $13.5B | |
| Current Liabilities | $272.7M | $508.9M | $452.7M | $489.1M | $440.6M | |
| Total Liabilities | $1.4B | $2.3B | $2B | $2B | $2B | |
| Total Equity | $9.3B | $10.3B | $9.7B | $10.3B | $11.5B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.4B | $1.2B | $1.7B | -$157.4M | -$281.9M | |
| Cash From Investing | -$41.5M | $128.2M | -$177.5M | $90.1M | -$22.5M | |
| Cash From Financing | -$2.1B | -$1.1B | -$936.6M | -$461.4M | -$208.4M | |
| Free Cash Flow | $2.1B | $911.2M | $1.3B | -$239.3M | -$394.9M | |
TROW
Sector
Market Cap
$21.1B
$625.8M
Price % of 52-Week High
75.27%
86.55%
Dividend Yield
5.27%
1.95%
Shareholder Yield
5.72%
3.76%
1-Year Price Total Return
-21.65%
9.43%
Beta (5-Year)
1.465
0.712
Dividend yield:
5.27%
Annualized payout:
$4.96
Payout ratio:
54.07%
Growth streak:
2 years
Technicals
8-day SMA
Buy
Level
$94.26
200-day SMA
Sell
Level
$111.29
Bollinger Bands (100)
Sell
Level
102.78 - 120.5
Chaikin Money Flow
Buy
Level
356.3M
20-day SMA
Sell
Level
$96.84
Relative Strength Index (RSI14)
Sell
Level
37.50
ADX Line
Sell
Level
41.44
Williams %R
Neutral
Level
-66.3041
50-day SMA
Sell
Level
$105.49
MACD (12, 26)
Sell
Level
-3.39
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
150.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.9342)
Buy
CA Score
(Annual)
Level (1.8617)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-6.2932)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load us and international stock, hybrid, bond, and money market funds. At the end of October 2024, the firm had $1.607 trillion in managed assets, composed of equity (51%), balanced (34%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a us-based asset manager, deriving less than 10% of its AUM from overseas.
Stock Forecast FAQ
In the current month, TROW has received 0 Buy ratings 9 Hold ratings, and 0 Sell ratings. The TROW average analyst price target in the past 3 months is $110.54.
-
Where Will T. Rowe Price Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that T. Rowe Price Group share price will rise to $110.54 per share over the next 12 months.
-
What Do Analysts Say About T. Rowe Price Group?
Analysts are divided on their view about T. Rowe Price Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that T. Rowe Price Group is a Sell and believe this share price will drop from its current level to $90.00.
-
What Is T. Rowe Price Group's Price Target?
The price target for T. Rowe Price Group over the next 1-year time period is forecast to be $110.54 according to 9 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is TROW A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for T. Rowe Price Group is a Hold. 9 of 9 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TROW?
You can purchase shares of T. Rowe Price Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase T. Rowe Price Group shares.
-
What Is The T. Rowe Price Group Share Price Today?
T. Rowe Price Group was last trading at $91.55 per share. This represents the most recent stock quote for T. Rowe Price Group. Yesterday, T. Rowe Price Group closed at $94.70 per share.
-
How To Buy T. Rowe Price Group Stock Online?
In order to purchase T. Rowe Price Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is up 0.71% over the past day.
